http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-012489-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d608dce60e3ea87ec7fb0b40f1cb31a4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2d3599fb8f8f479dba95ca9bb504884
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-30
filingDate 1998-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2000-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AR-012489-A1
titleOfInvention CORTICOTROPIN RELEASE FACTOR THIOPHENOPYRIDINE ANTAGONISTS. PROCEDURE FOR ITS PREPARATION, THE USE OF THE SAME IN THE PREPARATION OF A MEDICINAL PRODUCT, PHARMACEUTICAL COMPOSITION THAT INCLUDES THEM, PROCEDURE FOR THE PREPARATION OF SUCH COMPOSITION, AN INTERMEDIATE COMPOUND AND
abstract Thiophenopyridines corticotropin releasing factor antagonists of formula (I), including the stereoisomers and the pharmaceutically acceptable acid addition salt forms thereof, where X is S or SO2; R1 is C1-6 alkyl, NR5 R6, OR6, or SR6; R2 is C1-6alkyl, C1-6alkyloxy or C1-6alkylthio; R3 is Ar1 or Het1; R4 is hydrogen, or C1-6 alkyl; R5 is hydrogen, C1-8 alkyl, mono- or di (C3-6 cycloalkyl) methyl, C3-6 cycloalkyl, C3-6 alkenyl, hydroxyC1-6alkyl, C1-6alkylcarbonyloxyC1-6alkyl or C1-6alkyloxy alkyl C1-6; R6 is C1-8 alkyl, mono- or di (C3-6 cycloalkyl) methyl, Ar2CH2, C1-6 alkyloxy C1-6 alkyl, hydroxyalkyl C1-6, thienylmethyl, furanylmethyl, C 1-6 alkylthio, C 1-6 alkyl mono or di (C 1-6 alkyl) amino C 1-6 alkyl, di (C 1-6 alkyl) amino, C 1-6 alkylcarbonyl C 1-6 alkyl; or R5 and R6 taken together with the nitrogen atom to which they are attached can form a pyrrolidinyl, piperidinyl, homopiperidinyl, or morpholinyl group, optionally substituted with C1-6alkyl or C1-6alkyloxyC1-6alkyl; and Ar1 is phenyl; phenyl substituted with 1, 2 or 3 substituents each independently selected from halo, C1-6alkyl, trifluoromethyl, hydroxy, cyano, C1-6alkyloxy, benzyloxy, C1-6alkylthio, nitro, amino and mono- or di - (C1-6 alkyl) amino; Ar2 is phenyl, phenyl substituted with 1, 2 or 3 substituents each independently selected from halo, C1-6alkyl, C1-6alkyloxy, di (C1-6alkyl) aminoC1-6alkyl, trifluoromethyl; and Het1 is pyridinyl, pyridinyl substituted with 1, 2 or 3 substituents each independently selected from halo, C1-6alkyl, trifluoromethyl, hydroxy i, cyano, C1-6alkyloxy, benzyloxy, C1-6alkylthio, nitro amino and mono- or di- (C1-6 alkyl) amino; Y
priorityDate 1997-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454973655
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394859
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID373802
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457444288
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457311044
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16132265
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID380532
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394843
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419581612

Total number of triples: 33.